entertainment -WSS

entertainment

author：leisure time 2025-09-30 00:50:21 - browse：22

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： FDA approves world's first CRISPR

focus

WSS

A look at other Americans who have crossed into North Korea over the years

Manchin plays down potential 3rd

Radiology is caught between AI's potential and concern for patients

CMS should re

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Flagship, Pfizer team up in deal worth up to $7 billion

entertainment

entertainment

focus

Supreme Court strikes down use of affirmative action

US soldier in North Korean custody after crossing DMZ line

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A look at other Americans who have crossed into North Korea over the years

What does generative AI mean for health care? We asked experts

What we know about the American soldier detained in North Korea

Heart attack and stroke risk calculators need revising

Biden administration sends mixed signals on US soldier who crossed into North Korea

Hollywood unions extend contract negotiations for actors

FDA approves world's first CRISPR

focus

Pfizer plans to depart BIO

ER docs worry over extreme heat as a 'mass casualty event'

What PEPFAR has meant on the ground in Ukraine

AI models in health care face new federal disclosure requirements

SCOTUS to consider access to abortion pill mifepristone

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

entertainment

focus

hotspot

explore